ReMindCare, an app for daily clinical practice in patients with first episode psychosis: A pragmatic real-world study protocol.
ReMindCare, an app for daily clinical practice in patients with first episode psychosis: A pragmatic real-world study protocol.
复制标题
DOI：
10.1111/eip.12960
复制
发表时间：
2021-03
影响因子：
2
通讯作者：
Sanjuán J
中科院分区：
文献类型：
--
作者：
Bonet L;Torous J;Arce D;Blanquer I;Sanjuán J
尽管电子健康干预对精神病患者有潜在的好处，但将这些应用程序整合到临床工作流程中并分析其长期影响仍然面临重大挑战。为了解决这些问题，我们开发了ReMindCare应用程序。该应用程序旨在提高精神病患者的治疗质量。我们选择在真实的世界中以务实的方式研究该应用程序，以确保结果具有普遍性。这是一个自然主义的经验性研究的病人在第一次发作的精神病计划。该应用程序是基于之前的两项研究而设计的，它提供了以下评估：（a）关于焦虑，悲伤和易怒的三个日常问题;（B）关于药物依从性，药物副作用，药物态度和前驱症状的18个每周问题。该应用程序提供预设警报，提醒和患者联系临床医生的能力。应用程序捕获的数据将链接到患者的电子病历。患者将使用该应用程序作为其持续护理的一部分，最长为期5年，评估将在基线时以及应用程序使用的第一年、第二年和第五年结束时进行。招聘于2018年10月开始，目前仍在进行中。ReMindCare应用程序代表了数字心理健康工具的早期真实的使用，这些工具可直接集成到临床护理中。预计保留率和依从率较高，这将反过来导致评估质量的提高以及患者和临床医生之间的沟通。
Despite the potential benefits of e‐health interventions for patients with psychosis, the integration of these applications into the clinical workflow and analysis of their long‐term effects still face significant challenges. To address these issues, we developed the ReMindCare app. This app aims to improve the treatment quality for patients with psychosis. We chose to study the app in real world and pragmatic manner to ensure results will be generalizable. This is a naturalistic empirical study of patients in a first episode of psychosis programme. The app was purpose‐designed based on two previous studies, and it offers the following assessments: (a) three daily questions regarding anxiety, sadness and irritability; and (b) 18 weekly questions about medication adherence, medication side effects, medication attitudes and prodromal symptoms. The app offers preset alerts, reminders and the ability for patients to reach out to their clinicians. Data captured by the app are linked to the electronic medical record of the patient. Patients will use the app as part of their ongoing care for a maximum period of 5 years, and assessments will occur at baseline and at the end of the first, second and fifth years of app use. Recruitment started in October 2018 and is still ongoing. The ReMindCare app represents early real‐world use of digital mental health tools that offer direct integration into clinical care. High retention and compliance rates are expected, and this will in turn lead to improved quality of assessments and communication between patients and clinicians.
登录
查看更多内容
DOI：
10.1016/j.ijmedinf.2013.10.009
发表时间：
2014-07-01
影响因子：
4.9
作者：
Abbott, Patricia A.;Foster, Joanne;Dykes, Patricia C.
通讯作者：
Dykes, Patricia C.
影响因子：
6.6
作者：
Firth, Joseph;Cotter, Jack;Yung, Alison R.
通讯作者：
Yung, Alison R.
影响因子：
0.7
作者：
Gitlow, Lynn;Abdelaal, Farrah;Toner, Meagan
通讯作者：
Toner, Meagan
影响因子：
7.4
作者：
Baumel, Amit;Faber, Keren;Muench, Fred
通讯作者：
Muench, Fred
影响因子：
7.4
作者：
Berry N;Lobban F;Emsley R;Bucci S
通讯作者：
Bucci S